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Kaposi’s sarcoma (KS) is an angioproliferative tumor of
vascular endothelial cells and produces rare B cell lym-
phoproliferative diseases in the form of primary effusion
lymphomas (PELs) and some forms of Multicentric Cas-
tleman’s Disease (MCD). Kaposi’s sarcoma-associated
herpesvirus, also known as KSHV or human herpesvirus
type 8 (HHV8), is the etiological agent of KS. Fibulins
are extra-cellular matrix (ECM) proteins involved in cell
adhesion, proliferation, migration, invasion, and angio-
genesis, and have been linked to progression of several
cancer types. However, to our knowledge, they have not
been studied in KS. We examined fibulin-2 because we
found it to be significantly downregulated by microarray
analysis in KSHV-infected DMVEC cells. Here we
demonstrate that fibulin-2 protein expression is downre-
gulated 50-fold in 10 day KSHV-infected dermal micro-
vascular endothelial cells (DMVEC) with a 26-fold
reduction in fibulin-2 message. By time-course tran-
scriptional analysis there was consistent reduction of
fibulin-2 message accompanied by an increase in KSHV
latency associated nuclear antigen (LANA) transcription.
Of the fibulins assayed, fibulins -2, -5, and -3 were
downregulated over time in KSHV infected DMVEC,
while fibulins 1C and 1D were upregulated, with no
change in fibulins 4, 6, and 7. In pleural effusion lym-
phoma cell lines that express different levels of KSHV
lytic replication, we observed no detectable fibulin-2
expression. Tissue microarrays representing patch/pla-
que and nodular forms of KS from 86 different patients
were shown to be statistically significant for downregu-
lation of fibulin-2 in virus-infected LANA positive cells
by dual labeled immunohistochemical staining. This
represents the first study that examines fibulin-2 expres-
sion in KSHV-infected DMVEC and KS to determine
whether suppression of this ECM protein plays a role in
KS tumor progression. Understanding the interactions
between KSHV and the fibulin family of extra-cellular
matrix proteins that modulate angiogenesis cancer cell
proliferation, migration and invasion could lead to
development of novel therapies for treatment of KS.
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